By Date


  • 6-April-2016

    English

    International Trade in Health Services

    Medical tourism is apparently growing rapidly and yet there is little data on the extent of the provision of health care services across borders. This OECD paper identifies the key emerging policy issues relating to the rise in this new market.

    Related Documents
  • 4-April-2016

    English

    The doctor will see you now (if you turn on the video)

    An elderly man with cardiovascular disease tests his own blood pressure, and sends the results to an online application that his doctor can access. Another patient with depression living in a rural area far from health services tells a psychiatrist how he is feeling via a video connection. All of this occurs without the patients leaving their homes.

    Related Documents
  • 31-March-2016

    English, PDF, 367kb

    Greece Policy Brief: Controlling Spending While Improving Access and Quality of Health Services

    Public health spending in Greece fell by a third in real-terms between 2009 and 2013, with severe cuts across the board and changes to entitlement, benefits and user charges.

    Related Documents
  • 31-March-2016

    English

    OECD Reviews of Labour Market and Social Policies: Latvia 2016

    Latvia has undergone major economic and social change since the early 1990s. Despite an exceptionally deep recession following the global financial crisis, impressive economic growth over the past two decades has narrowed income and productivity gaps relative to comparator countries in the OECD. But Latvians report low degrees of life satisfaction, very large numbers of Latvians have left the country, and growth has not been inclusive. A volatile economy and very large income disparities create pressing needs for more effective social and labour-market policies. The government’s reform programme rightly acknowledges inequality as a key challenge. However, without sustained policy efforts and adequate resources, there is a risk that productivity and income growth could remain below potential and social cohesion could be further weakened by high or rising inequality.

  • 23-March-2016

    English

    High-Level Commission on Health Employment and Economic Growth: closing remarks

    Thank you for today’s inspiring and productive conversation. Many important points have been raised that will be very helpful in guiding the future work of the Commission. Three key messages have emerged.

  • 23-March-2016

    English

    High-Level Commission on Health Employment and Economic Growth: opening remarks

    Our discussions today can help us identify clear, bold and actionable policies for better health workforce strategies. The OECD is delighted to join WHO and ILO in coordinating the work of the High-Level Commission on Health Employment and Economic Growth. We stand ready to share our knowledge, tools, data and experience to ensure its success.

  • 23-March-2016

    English

    Launch of the UNSG High-Level Commission on Health Employment and Economic Growth with Angel Gurría as co-vice chair

    Launch and first meeting of the Commission, Lyon, France. The meeting was chaired by H.E. Mr François Hollande, President of France and, H.E. Mr Jacob Zuma, President of South Africa.

    Related Documents
  • 23-mars-2016

    Français

    Personnels de santé

    Les personnels de santé sont essentiels pour assurer l'accès à des soins de qualité pour toute la population. Le travail de l'OCDE examine les tendances et les priorités en ce qui concerne les politiques en matière de personnels de santé dans les pays de l'OCDE.

    Documents connexes
    Also AvailableEgalement disponible(s)
  • 16-March-2016

    English

    Pharmaceutical Pricing Policy project

    The policy study published by the OECD is based on six case studies, an extensive review of the literature, and analysis of relevant data. The report provides context for the analysis of pharmaceutical pricing policies in OECD countries, describes pricing policies employed by the OECD zone and assesses their impact.

  • 16-March-2016

    English

    Value in Pharmaceutical Pricing

    The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>